Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-26-126539
Filing Date
2026-03-26
Accepted
2026-03-26 17:01:36
Documents
15
Effectiveness Date
2026-03-26

Document Format Files

Seq Description Document Type Size
1 S-8 d139369ds8.htm S-8 57016
2 EX-5.1 d139369dex51.htm EX-5.1 8929
3 EX-23.1 d139369dex231.htm EX-23.1 1792
4 EX-99.5 d139369dex995.htm EX-99.5 17263
5 EX-FILING FEES d139369dexfilingfees.htm   iXBRL EX-FILING FEES 21179
6 GRAPHIC g139369g0325113645210.jpg GRAPHIC 3617
  Complete submission text file 0001193125-26-126539.txt   236825

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT d139369dexfilingfees_htm.xml XML 11681
Mailing Address 575 MADISON AVENUE NEW YORK NY 10022
Business Address 575 MADISON AVENUE NEW YORK NY 10022 917-450-6581
LB PHARMACEUTICALS INC (Filer) CIK: 0001691082 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-294656 | Film No.: 26799164
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)